NCT03761797View on ClinicalTrials.gov

A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

1,164

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

March 10, 2021

Study Completion Date

April 27, 2021

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

TRADIANCE® Combination Tablets AP

Fixed dose combination

DRUG

TRADIANCE® Combination Tablets BP

Fixed dose combination

Trial Locations (1)

1416017

Nippon Boehringer Ingelheim Co., Ltd, Tokyo

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY